erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
new research shows a growing number of young people are thinking about taking their own lives, and the study suggests school stress may play a role...
.